Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action

Ivermectin is an antiparasitic drug that has shown also an effective pharmacological activity towards various infective agents, including viruses. This paper proposes an alternative mechanism of action for this drug that makes it capable of having an antiviral action, also against the novel coronavi...

Descripción completa

Detalles Bibliográficos
Autor principal: Rizzo, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251046/
https://www.ncbi.nlm.nih.gov/pubmed/32462282
http://dx.doi.org/10.1007/s00210-020-01902-5
_version_ 1783538879909855232
author Rizzo, Emanuele
author_facet Rizzo, Emanuele
author_sort Rizzo, Emanuele
collection PubMed
description Ivermectin is an antiparasitic drug that has shown also an effective pharmacological activity towards various infective agents, including viruses. This paper proposes an alternative mechanism of action for this drug that makes it capable of having an antiviral action, also against the novel coronavirus, in addition to the processes already reported in literature.
format Online
Article
Text
id pubmed-7251046
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-72510462020-05-27 Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action Rizzo, Emanuele Naunyn Schmiedebergs Arch Pharmacol Brief Communication Ivermectin is an antiparasitic drug that has shown also an effective pharmacological activity towards various infective agents, including viruses. This paper proposes an alternative mechanism of action for this drug that makes it capable of having an antiviral action, also against the novel coronavirus, in addition to the processes already reported in literature. Springer Berlin Heidelberg 2020-05-27 2020 /pmc/articles/PMC7251046/ /pubmed/32462282 http://dx.doi.org/10.1007/s00210-020-01902-5 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Brief Communication
Rizzo, Emanuele
Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action
title Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action
title_full Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action
title_fullStr Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action
title_full_unstemmed Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action
title_short Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action
title_sort ivermectin, antiviral properties and covid-19: a possible new mechanism of action
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251046/
https://www.ncbi.nlm.nih.gov/pubmed/32462282
http://dx.doi.org/10.1007/s00210-020-01902-5
work_keys_str_mv AT rizzoemanuele ivermectinantiviralpropertiesandcovid19apossiblenewmechanismofaction

Ejemplares similares